000			01792nam a2200121Ia 4500
008			220620s9999||||xx |||||||||||||| ||und||
100			_aKwok, Hang Fai (Henry)
245		0	_aVenom and Toxin as Targeted Therapy
546			_aEnglish[eng]
650			_acane toad||n/a||B cell non-Hodgkin lymphoma||Malaysian cobras||complement system||decay accelerating factor||neuroblastoma||atopic dermatitis||complement dependent cytotoxicity||antioxidant enzymes||bacterial adhesion||cancer therapy||N. kaouthia||anuran skin secretion||frog||Apis mellifera syriaca||solid phase extraction||bee venom phospholipase A2 (bvPLA2)||disintegrin||toad toxins||immunotoxins||ribosome-inactivating proteins||antimicrobial peptide (AMP)||drug design||Moxetumomab pasudotox||snake venom||antiviral activity||in vitro effects||bombesin-related peptide||oxidative stress biomarkers||half-life||blood vessel formation||target therapy||2||MYCN||indolealkylamines||Huachansu||membrane attack complex||bouganin||bee venom||SEM||anticancer activity||antimicrobial peptide||house dust mite extract (DFE)||mannose receptor||O. hannah||bicarinalin||gastric cells||melittin||LC-ESI-MS||dermaseptin||smooth muscle||apoptosis||anticancer||N. sumatrana||Helicobacter pylori||inflammation||immunotherapy||atopic dermatitis (AD)||immunotoxin||mantle cell lymphoma||clearance||mass spectrometry||Bougainvillea||rRNA N-glycosylase activity||fungal toxin||skin inflammation||targeted therapy||4-dinitrochlorobenzene (DNCB)||Bee venom||VEGF||Chansu||bufadienolides||obsessive–compulsive disorder (OCD)||BLF1||antimicrobial activity||orellanine||VB6-845||acute lymphoblastic leukemia||ribosome-inactivating protein||CD206||molecular cloning||cancer||CD22||eIF4A
856			_uhttps://mdpi.com/books/pdfview/book/1648
942			_cEB
999			_c29205 _d29205